Premium
Orally applied doxazosin disturbed testosterone homeostasis and changed the transcriptional profile of steroidogenic machinery, cAMP / cGMP signalling and adrenergic receptors in Leydig cells of adult rats
Author(s) -
Stojkov N. J.,
Janjic M. M.,
Kostic T. S.,
Andric S. A.
Publication year - 2013
Publication title -
andrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.947
H-Index - 43
eISSN - 2047-2927
pISSN - 2047-2919
DOI - 10.1111/j.2047-2927.2012.00035.x
Subject(s) - doxa , endocrinology , medicine , testosterone (patch) , homeostasis , biology , philosophy , epistemology
Summary Doxazosin (Doxa) is an α1‐selective adrenergic receptor (ADR) antagonist widely used, alone or in combination, to treat high blood pressure, benign prostatic hyperplasia symptoms, and recently has been suggested as a potential drug for prostate cancer prevention/treatment. This study was designed to evaluate the effect of in vivo Doxa po ‐application, in clinically relevant dose, on: (i) steroidogenic machinery homeostasis; (ii) cAMP / cGMP signalling; (iii) transcription profile of ADR in Leydig cells of adult rats. The results showed that po ‐application of Doxa for once (1×Doxa), or for two (2×Doxa) or 10 (10×Doxa) consecutive days significantly disturbed steroidogenic machinery homeostasis in Leydig cells. Doxa po ‐application significantly decreased circulating luteinizing hormone and androgens levels. The level of androgens in testicular interstitial fluid and that extracted from testes obtained from 1×Doxa/2×Doxa rats decreased, although it remained unchanged in 10×Doxa rats. Similarly, the ex vivo basal androgen production followed in testes isolated from 1×Doxa/2×Doxa rats decreased, while remained unchanged in 10×Doxa rats. Differently, ex vivo testosterone production and steroidogenic capacity of Leydig cells isolated from 1×Doxa/2×Doxa rats was stimulated, while 10×Doxa had opposite effect. In the same cells, cAMP content/release showed similar stimulatory effect, but back to control level in Leydig cells of 10×Doxa. 1×Doxa/2×Doxa decreased transcripts for cAMP specific phosphodiesterases Pde7b/Pde8b, whereas 10×Doxa increased Pde4d . All types of treatment reduced the expression of genes encoding protein kinase A (PRKA) regulatory subunit ( Prkar2b ), whereas only 10×Doxa stimulated catalytic subunit ( Prkaca) . Doxa application more affected cGMP signalling: stimulated transcription of constitutive nitric oxide synthases ( Nos1, Nos3 ) in time‐dependent manner, whereas reduced inducible Nos2 . 10×Doxa increased guanylyl cyclase 1 transcript and PRKG1 protein in Leydig cells. Orally applied Doxa significantly disturbed the transcriptional ‘signature’ of steroidogenic machinery, cAMP / cGMP signalling and ADRs and β‐ADRs kinases in Leydig cells, thus giving new molecular insights into the role of cAMP / cGMP /adrenalin signalling in Leydig cells homeostasis.